Report comment

Not sure how this really works:
What-if the Aquiring Trust is dragged down? Is it safe to think its Mgt & Culture are strong enough to deliver net gains for all of its Patients?
Will the synergy of getting rid of any redundant Duplication be sufficient to turn unviable into viable?
Are we just getting an over-funded Trust to cross-subsidise an under-funded Trust?
What if a Trust in a geographically remote area is deemed 'unviable' but nobody wants to Acquire it because its inherent business is deemed structurally 'flawed' under prevailing Funding Mechanism - who will serve its Patients?
In the Commercial arena, a competitor might Acquire a Target just to close it & remove it from the Market, but this might be very problematic for the NHS in many parts of the country outside of a few big cities.
Can we be Confident only Trusts with demonstrably Safer Hospitals + More Caring Nurses + More Skilled Medics + More Patient-friendly Processes + More Robust Finances will be allowed to acquire a Target?

So, I wonder what is the underlying problem that the FT Policy is meant to solve:
Inappropriate Funding Mechanisms?
Inadequate supply of competent Management?
Over Capacity to be rationalised by the effects of PFI Policy or non-Tariff Funding versus Clinical Outcomes & Efficiency?
A lack of Skills, Courage, or Processes to remove unwanted Capacity & Capability by Design?